Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

Open Access 01-11-2007 | Letter to the editor

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

Authors: Johannes W. van Isselt, John M. H. de Klerk, Cornelis J. M. Lips

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 11/2007

Excerpt

Dear Sir, …

Sisson JC, Avram AM, Rubello D, Gross MD. Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science? Eur J Nucl Med Mol Imaging 2007;34:1129–30.PubMedCrossRef

Anonymous. Richtlijn Schildklierfunctiestoornissen [in Dutch] http://www.internisten.nl/files/richtlijnschildklierfunctiestoornissendefinitiefmei2007.pdf

Wartofsky L, Glinoer D, Solomon B, Nagataki S, Lagasse R, Nagayama Y, Izumi M. Differences and similarities in the diagnosis and treatment of Graves’disease in Europe, Japan, and the United States. Thyroid 1991;1:129–35.PubMedCrossRef

Allahabadia A, Daykin J, Sheppard MC, Gouch SCL, Franklyn JA. Radioiodine treatment of hyperthyroidism—prognostic factors for outcome. J Clin Endocrinol Metab 2001;86:3611–7.PubMedCrossRef

Howarth D, Epstein M, Lan L, Tan P, Booker J. Determination of the optimal minimum radioiodine dose in patients with Graves’ disease: a clinical outcome study. Eur J Nucl Med 2001;28:1489–95.PubMedCrossRef

DeGroot LJ, Stanbury JB. Graves’ disease: diagnosis and treatment. In: DeGroot LJ, Stanbury JB, editors. The thyroid and its diseases, 4th edn. New York: Wiley; 1975. p. 314–67.

Aktay R, Rezai K, Seabold JE, Bar RS, Kirchner PT. Four- to twenty-four-hour uptake ratio: an index of rapid iodine-131 turnover in hyperthyroidism. J Nucl Med 1996;37:1815–9.PubMed

Himanka E, Larsson L. Estimation of thyroid volume. Acta Radiol 1955;43:125–31.PubMed

van Isselt JW, Beekman FJ, Kamphuis C, de Klerk JMH, Polman LJ, van Gils APG, Vincken K, van Rijk PP. Comparison of methods for thyroid volume estimation in patients with Graves’ disease. Eur J Nucl Med Mol Imaging 2003;30:525–31.PubMedCrossRef

10.

van Isselt JW, de Klerk JMH, Koppeschaar HPF, van Rijk PP. Iodine-131 uptake and turnover rate vary over short intervals in Graves’ disease. Nucl Med Commun 2000;21:609–16.PubMedCrossRef

11.

Berg GEB, Michanek AMK, Holmberg ECV, Fink M. Iodine-131 treatment of hyperthyroidism: significance of effective half-life measurements. J Nucl Med 1996;37:228–32.PubMed

12.

Grosso M, Traino A, Boni G, Banti E, Della Porta M, Manca G, et al. Comparison of different thyroid committed doses in radioiodine therapy for Graves’ hyperthyroidism. Cancer Biother Radiopharm 2005;20:218–23.PubMedCrossRef

Title: Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?
Authors: Johannes W. van Isselt
John M. H. de Klerk
Cornelis J. M. Lips
Publication date: 01-11-2007
Publisher: Springer-Verlag
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 11/2007
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-007-0592-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Radioiodine treatment of hyperthyroidism: fixed or calculated doses; intelligent design or science?

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 11/2007

Prognostic and diagnostic accuracy of [18F]FDG-PET/CT in 190 patients with carcinoma of unknown primary

[99mTc]Demotensin 5 and 6 in the NTS1-R-targeted imaging of tumours: synthesis and preclinical results

99mTc-chelator engineering to improve tumour targeting properties of a HER2-specific Affibody molecule

In vivo imaging of the endocannabinoid system: a novel window to a central modulatory mechanism in humans

Reply

The new EANM paediatric dosage card — does it conform to ALARA for PET/CT?